JP2024520555A5 - - Google Patents

Info

Publication number
JP2024520555A5
JP2024520555A5 JP2023573588A JP2023573588A JP2024520555A5 JP 2024520555 A5 JP2024520555 A5 JP 2024520555A5 JP 2023573588 A JP2023573588 A JP 2023573588A JP 2023573588 A JP2023573588 A JP 2023573588A JP 2024520555 A5 JP2024520555 A5 JP 2024520555A5
Authority
JP
Japan
Prior art keywords
asddna
chain
group
disorders
molecule according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023573588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520555A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/031658 external-priority patent/WO2022256351A1/en
Publication of JP2024520555A publication Critical patent/JP2024520555A/ja
Publication of JP2024520555A5 publication Critical patent/JP2024520555A5/ja
Pending legal-status Critical Current

Links

JP2023573588A 2021-05-29 2022-05-31 新規遺伝子サイレンシング技術としての非対称短鎖二重鎖dnaおよびその使用 Pending JP2024520555A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163195008P 2021-05-29 2021-05-29
US63/195,008 2021-05-29
PCT/US2022/031658 WO2022256351A1 (en) 2021-05-29 2022-05-31 Asymmetric short duplex dna as a novel gene silencing technology and use thereof

Publications (2)

Publication Number Publication Date
JP2024520555A JP2024520555A (ja) 2024-05-24
JP2024520555A5 true JP2024520555A5 (cg-RX-API-DMAC10.html) 2025-06-09

Family

ID=82361361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023573588A Pending JP2024520555A (ja) 2021-05-29 2022-05-31 新規遺伝子サイレンシング技術としての非対称短鎖二重鎖dnaおよびその使用

Country Status (9)

Country Link
US (1) US20240271137A1 (cg-RX-API-DMAC10.html)
EP (1) EP4347829A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024520555A (cg-RX-API-DMAC10.html)
KR (1) KR20240014532A (cg-RX-API-DMAC10.html)
CN (1) CN117858946A (cg-RX-API-DMAC10.html)
AU (1) AU2022285661A1 (cg-RX-API-DMAC10.html)
CA (1) CA3221935A1 (cg-RX-API-DMAC10.html)
TW (1) TW202309286A (cg-RX-API-DMAC10.html)
WO (1) WO2022256351A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024298074A1 (en) * 2023-07-21 2026-02-19 Bisirna Therapeutics Pte. Ltd. Double-stranded oligonucleotide agents and uses thereof
US20260199516A1 (en) * 2025-01-10 2026-07-16 Flagship Pioneering Innovations Vii, Llc Compositions and methods for delivery of dna to t cells

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100523215C (zh) 2000-12-01 2009-08-05 马普科技促进协会 介导rna干涉的小rna分子
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
CA2504694C (en) 2002-11-05 2013-10-01 Isis Pharmaceuticals, Inc. Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
DK1661905T3 (da) 2003-08-28 2012-07-23 Takeshi Imanishi Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
WO2005027962A1 (en) 2003-09-18 2005-03-31 Isis Pharmaceuticals, Inc. 4’-thionucleosides and oligomeric compounds
EP1799859B1 (en) 2004-09-17 2014-07-02 Isis Pharmaceuticals, Inc. Enhanced antisense oligonucleotides
DE602007009487D1 (de) 2006-01-27 2010-11-11 Isis Pharmaceutical Inc 6-modifizierte bicyclische nukleinsäureanaloga
EP2505646A1 (en) 2006-05-05 2012-10-03 Isis Pharmaceuticals, Inc. Compounds and methods for modulating expression of CRP
CA2651453C (en) 2006-05-11 2014-10-14 Isis Pharmaceuticals, Inc. 5'-modified bicyclic nucleic acid analogs
US20100190837A1 (en) 2007-02-15 2010-07-29 Isis Pharmaceuticals, Inc. 5'-Substituted-2-F' Modified Nucleosides and Oligomeric Compounds Prepared Therefrom
DK2170917T3 (da) 2007-05-30 2012-10-08 Isis Pharmaceuticals Inc N-Substituerede bicycliske nukleinsyreanaloge med aminomethylenbro
WO2008154401A2 (en) 2007-06-08 2008-12-18 Isis Pharmaceuticals, Inc. Carbocyclic bicyclic nucleic acid analogs
AU2008272918B2 (en) 2007-07-05 2012-09-13 Isis Pharmaceuticals, Inc. 6-disubstituted bicyclic nucleic acid analogs
EP3121281B1 (en) 2007-08-27 2021-03-31 1Globe Health Institute LLC Compositions of asymmetric interfering rna and uses thereof
KR20110110776A (ko) * 2008-12-18 2011-10-07 다이서나 파마수이티컬, 인크. 유전자 발현의 특이적 억제를 위한 연장된 다이서 기질 제제 및 방법
JP6472087B2 (ja) * 2013-05-30 2019-02-27 国立大学法人 東京医科歯科大学 治療用オリゴヌクレオチドを送達するための二本鎖剤
JPWO2017068790A1 (ja) * 2015-10-23 2018-08-09 レナセラピューティクス株式会社 核酸複合体
US11260134B2 (en) * 2016-09-29 2022-03-01 National University Corporation Tokyo Medical And Dental University Double-stranded nucleic acid complex having overhang

Similar Documents

Publication Publication Date Title
TWI823866B (zh) 用於抑制類血管生成素蛋白-3(ANGPTL3)表現的RNAi藥劑及組合物及使用方法
TWI784934B (zh) 抑制lpa之基因表現之組合物及方法
CN110832077B (zh) 用于抑制α-ENaC表达的RNAi剂及使用方法
TW201639962A (zh) Rna干擾劑
CN105121452A (zh) 三环核苷和由其制备的寡聚化合物
EP4653532A2 (en) Advanced rna targeting (arnatar)
CN111902537A (zh) Dnm2表达的调节剂
JP7453921B2 (ja) Gys2発現を阻害するための組成物及び方法
CN104321334A (zh) 三环核苷及由其制备的低聚化合物
WO2019044974A1 (ja) スモールガイドアンチセンス核酸とその使用
EP4671372A2 (en) Translation-enhancing nucleic acid compounds: Upward regulation 1 coupled with ASO (ACT-UP1) and their uses
JP2024520556A5 (cg-RX-API-DMAC10.html)
WO2024040041A1 (en) Regulation of activity of rnai molecules
TW202309286A (zh) 作為新穎基因靜默技術的非對稱短雙股dna及其應用
JP7128517B2 (ja) 副作用を減じたアンチセンス核酸
Pontarelli et al. Arabinonucleic acids containing C5-propynyl modifications form stable hybrid duplexes with RNA that are efficiently degraded by E. coli RNase H
US20240336920A1 (en) Threose nucleic acid antisense oligonucleotides and methods thereof
CN121127248A (zh) 用于抑制线粒体偕胺肟还原组分1 (MARC1)表达的RNAi剂、其药用组合物及使用方法
JP2025542580A (ja) 遺伝子サイレンシング技術としての、デオキシリボヌクレオチドが散在している短鎖二重鎖rna、およびその使用
TW202313977A (zh) 作為新穎基因靜默技術的短雙股dna及其應用
JP7216381B2 (ja) Rna作用抑制剤及びその利用
JP7776420B2 (ja) Ataxin 3発現を調節するための化合物、方法及び医薬組成物
HK40129500A (en) Translation enhancing nucleic acid compounds: aso coupled translation - upregulation 1 (act-up1) and uses thereof
JP2023127484A (ja) 塩基部修飾ヌクレオシドを含む新規アンチセンス核酸
HK40108297A (en) Short duplex dna as a novel gene silencing technology and use thereof